The malaria diagnostics market was worth
USD 579.5 million in 2015 owing to rising prevalence of the disease worldwide.
The market is projected to reach USD 789.0 million over the forecast period. In
addition to growing need for technological advancements, there is rising demand
for cost-efficient and high-quality diagnostics methodologies that can trigger
growth in the industry.
The
diagnostics market can be segmented into rapid diagnostic tests (RDTs) and
microscopic devices. RDT malaria diagnostic market accounted for a share of
about 45.0% in the year 2015, in terms of revenue and is expected to continue
the trend with the highest CAGR over the forecast period. Need for faster
results, growing sensitivity and shortage of skilled workforce are key factors
driving the industry. Also, RDTs require less turnaround time and are
comparatively simple to use, which is expected to propel demand. The
microscopic malaria diagnostics share, by volume, is anticipated to grow at a
CAGR of about 3.7% over the next seven years.
Rising
poverty, improper weather conditions, inadequate medical facilities, and high
prevalence of, P. falciparum have resulted in increased rate of malaria in
Africa. The region contributed to over 58.0% by volume in 2015 and is expected
to witness a rise in the share to reach about 60.0% by 2022.
Microscopy
technology dominated the MD market with more than 190 million patients
diagnosed by this methodology in 2013. India was the key market for this
technology and witnessed about 120 slide examinations in 2013. The MD industry in
the economy is expected to grow at 3.85% over the forecast period.
To request a
sample copy or view summary of this report, click the link below:
Further key findings from the study suggest:
- South-East Asia occupied the second largest share globally and is projected to increase at a CAGR of about 4.0% from 2015 to 2022. Countries including Sri Lanka have witnessed a decrease in malaria occurrences by focusing on prevention of the disease via reintroduction phase.
- The industry is consolidated with few companies occupying the dominant share in the market. The companies have been involved in new product development through technological innovation, collaborations, partnerships and joint ventures. In March 2015, Standard Diagnostics/Alere extended their alliance with FIND that involves developing a pioneering RDT for malaria along with human African trypanosomiasis commonly known as sleeping sickness. Some key players include Access Bio Inc., Premier Medical Corporation, bioMerieux, and Beckman Coulter Inc.
See More
Reports of This Category:
About
Grand View Research:
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:
sales@grandviewresearch.com
No comments:
Post a Comment